- Home
- RMBI vs ELTX Comparison
RMBI vs ELTX Comparison
Compare RMBI & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RMBI | ELTX |
|---|---|---|
| Founded | 1887 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 130.5M | 209.9M |
| IPO Year | 2019 | 2014 |
Fundamental Metrics
Financial Performance| Metric | RMBI | ELTX |
|---|---|---|
| Price | $14.16 | $11.77 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 13.8K | ★ 99.9K |
| Earning Date | 04-24-2026 | 05-12-2026 |
| Dividend Yield | ★ 4.30% | N/A |
| EPS Growth | 27.17 | ★ 39.29 |
| EPS | ★ 1.17 | N/A |
| Revenue | N/A | ★ $2,301,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.93 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.61 | $4.70 |
| 52 Week High | $15.24 | $14.93 |
Technical Indicators
Market Signals| Indicator | RMBI | ELTX |
|---|---|---|
| Relative Strength Index (RSI) | 54.87 | 60.16 |
| Support Level | $13.68 | $9.99 |
| Resistance Level | $14.41 | $12.52 |
| Average True Range (ATR) | 0.28 | 0.85 |
| MACD | 0.08 | 0.08 |
| Stochastic Oscillator | 62.50 | 83.61 |
Price Performance
Historical ComparisonAbout RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. The company has one reportable segment which is Community Banking.
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.